XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 25.70

-3.6%

Jan 26 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: aknahow who wrote (9063)	3/9/1999 10:47:00 PM
From: Bluegreen	Read Replies (1) of 17367

As stated in the previous post about incidents sloping off and only mention by Jack Castello that we are close to mortality requirement number but no mention of how close to ending trial, in my opinion I see us going into next season. Some of you may laugh at that, but we shall see. Maybe this trial is still "flexible" enough also that there may be something else besides mortality requirement that calls for further extension? My opinion also at this point is stock will drift much lower over time as season for Meningo. winds down. Spring is only a couple of weeks away. Those top guns at St. Mary's will more than likely only get better over time also just using conventional therapies in reducing mortality which is a godsend for the kids. Once again only my opinions, I could be entirely wrong.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next